MedTrace Logo

Dezocine for Prevention of Catheter-related Bladder Discomfort

NCT03147066 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2017-10-31

No results posted yet for this study

Summary

This study evaluates the efficacy of dezocine in preventing the catheter-related bladder discomfort (CRBD) in a postanesthesia care unit (PACU).

Conditions

  • Catheter Related Bladder Discomfort

Interventions

DRUG

Dezocine

Dezocine (0.1 mg/kg）will be infused during surgery

DRUG

Flurbiprofen Axetil

Flurbiprofen Axetil (1 mg/kg）will be infused during surgery

Sponsors & Collaborators

  • Jian-jun Yang

    lead OTHER

Principal Investigators

  • Jian-jun Yang, PhD · Zhongda Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2017-10-30
Completion
2017-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03147066 on ClinicalTrials.gov